聖濟堂(600227.SH):資產重組公開掛牌未徵集到符合條件的意向受讓方
格隆匯5月20日丨聖濟堂(600227.SH)公告,公司於2020年4月14日收到貴州陽光產權交易所出具的《信息披露截止的情況説明》,貴州赤天化桐梓化工有限公司100%股權項目自2020年3月30日發佈信息披露起,至2020年4月13日信息披露截止,未有意向受讓方向貴州陽光產權交易所提交受讓標的項目所需申請及相關資料。由於本次公開掛牌未能徵集到符合條件的意向受讓方,公司將重新召開董事會審議標的資產的後續處置事宜。公司將根據事項的進展情況及時履行信息披露義務,敬請廣大投資者注意投資風險。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.